OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78‐week prospective study
Xiaoqin Dong, Zhao Wu, ­Jun Li­, et al.
Journal of Gastroenterology and Hepatology (2018) Vol. 34, Iss. 4, pp. 755-763
Closed Access | Times Cited: 25

Showing 25 citing articles:

Advances in non-invasive assessment of hepatic fibrosis
Rohit Loomba, Leon A. Adams
Gut (2020) Vol. 69, Iss. 7, pp. 1343-1352
Open Access | Times Cited: 267

Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2

A machine learning based algorithm accurately stages liver disease by quantification of arteries
Zhengxin Li, Xin Sun, Zhimin Zhao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
Chinmay Bera, Nashla Hamdan‐Pérez, Keyur Patel
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1046-1046
Open Access | Times Cited: 6

KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease
Mi Na Kim, Ji Won Han, Jihyun An, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. Suppl, pp. S5-S105
Open Access | Times Cited: 6

Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
Asgeir Johannessen, Dag Henrik Reikvam, Soo Aleman, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 4, pp. 434-445
Open Access | Times Cited: 5

Regression of liver fibrosis: evidence and challenges
Yameng Sun, Shuyan Chen, Hong You
Chinese Medical Journal (2020) Vol. 133, Iss. 14, pp. 1696-1702
Open Access | Times Cited: 38

Past, present, and future of long-term treatment for hepatitis B virus
Teresa Broquetas, J.A. Carrión
World Journal of Gastroenterology (2023) Vol. 29, Iss. 25, pp. 3964-3983
Open Access | Times Cited: 13

Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B
Dong Ji, Yan Chen, Qinghua Shang, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 8, pp. 1676-1685
Open Access | Times Cited: 27

Consensus on the diagnosis and treatment of hepatic fibrosis (2019)

Journal of Digestive Diseases (2020) Vol. 21, Iss. 3, pp. 127-138
Closed Access | Times Cited: 24

Staging Fibrosis in Chronic Viral Hepatitis
Ana Carolina Cardoso, C. Figueiredo-Mendes, Cristiane Alves Villela‐Nogueira, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 660-660
Open Access | Times Cited: 14

Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus
Teresa Broquetas, J.A. Carrión
Hepatic Medicine Evidence and Research (2022) Vol. Volume 14, pp. 87-100
Open Access | Times Cited: 13

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
Xiujuan Chang, Chao Sun, Yan Chen, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 32, pp. 4764-4778
Open Access | Times Cited: 18

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study
Leijie Wang, Mingyu Zhu, Lihua Cao, et al.
Journal of Clinical and Translational Hepatology (2019) Vol. 7, Iss. X, pp. 1-9
Open Access | Times Cited: 12

Dose–response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B
Chi Zhang, Yiqi Liu, Lin Wang, et al.
Hepatology International (2024) Vol. 18, Iss. 5, pp. 1434-1447
Open Access | Times Cited: 1

Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase
Lingling Huang, Xueping Yu, Qing-Fa Ruan, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2

The Combination of Shear Wave Elastography and Platelet Counts Can Effectively Predict High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis
Xiaoyu Xie, Yuemin Feng, Zhuozhen Lyu, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 5

Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection
­Jun Li­, Xiaoqin Dong, Zhao Wu, et al.
Chinese Medical Journal (2019) Vol. 132, Iss. 22, pp. 2647-2656
Open Access | Times Cited: 3

Liver cirrhosis reversal and recompensation: Existing evidence and future prospects
Tao Du, Bing Yu, Wei Luo
Shijie huaren xiaohua zazhi (2024) Vol. 32, Iss. 5, pp. 320-326
Open Access

The Early On-treatment Stiffness Decline Attributed to the Improved Hepatic Inflammation in Fibrotic Chronic Hepatitis B
Mingwei Li, Mingjie Yao, Leijie Wang, et al.
Journal of Clinical Gastroenterology (2024)
Closed Access

Hepatit B Enfeksiyonunda Karaciğer Histopatolojik Evreleri ile Albumin-Bilirubin Skoru Arasındaki İlişki
Harun Erdal, Ayfer Bakır, Mustafa Güney, et al.
Düzce Tıp Fakültesi Dergisi (2022) Vol. 24, Iss. 1, pp. 60-66
Open Access | Times Cited: 1

Serum HBV RNA is associated with liver fibrosis regression in HBeAg‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues
Dan‐Dan Bian, Jing Zhao, Hao Liao, et al.
Journal of Viral Hepatitis (2022) Vol. 30, Iss. 4, pp. 303-309
Closed Access | Times Cited: 1

Management of ACLD After HBV-Suppression and HCV-Cure
Jidong Jia, Sabela Lens, Hitoshi Yoshiji, et al.
Springer eBooks (2022), pp. 239-252
Closed Access

Page 1

Scroll to top